CTXRNasdaqPharmaceutical Preparations

Citius Pharmaceuticals, Inc. (CTXR) earnings date, market-implied expected move, and options open interest by expiry

0.53

pre 0.57 −1.43%

Pre-market07:00 ETdelayed

Open0.57Volume98,273Mkt cap$15.7M

Day0.57 – 0.5750%52-wk0.37 – 1.5417%

CTXR

Citius Pharmaceuticals, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 12

before open · in 100 days

est.Q1 FY27

Calendar

Next report

Last report

+11.62%

shaded = implied · ▲▼ = realized

Oct 26 '26 · confirmed

Implied vs realized

Linked news

48mRDY · supplierDR Reddys allots 5,91,270 equity shares on exercise of employee stock options
1hCOR · customerCencora reports Q4 revenue $88.4 billion, GAAP diluted EPS $2.71; FY27 adj EPS $19.40 to $19.75
34dCAH · customerCardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

News

Largest filed tie

13F top-10 QoQ

+44.36%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

41 managers

Top fund weight

—

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Citius Pharmaceuticals (CTXR) is expected to report on Feb 12 before open (estimated date).

Implied vs realized

2 reports

—≥ implied

Q3 FY26Aug 14 '26confirmed±41.1%▼−25.62%×0.62

Oct 26 '26Oct 26 '26confirmed—▲+11.62%—

quarterimplied−45%0+45%realized×

Oct '26—▲+11.62%—

Q3 FY26±41.1%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

0.00OI · 3 expiries · Nov 3 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

80%Nov 2016d0.01538+10%0.01

0—Dec 1844d0.00100—0.00

report · Feb 12 · before open · est.

0—Feb 19107d5330%

ExpiryPutsCallsP/C

Nov 2016d80%538+10%0.01

Dec 1844d0—100—0.00

report · Feb 12 · before open · est.

Feb 19107d0

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−797.92%as filednet margin · revenue −10.41% QoQ

Revenue$1M−10.41%

Gross profit$1M67.07%−25.14%

Operating income−$12M−785.39%+63.56%

Pre-tax income−$12M+57.56%

Net income−$12M−797.92%+57.60%

Cost of revenue$491,843+49.55%

Operating expenses$13M−62.03%

Tax−$107,347+53.57%

Other expense−$294,533−107.64%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

No trades yet today.

Intraday

Event sensitivity

PCE ×1.35· ±6.4% vs ±4.8% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±6.4%9 of 19×1.35

NFPjobs report±5.1%3 of 10×1.07

GDPgross domestic product±5.1%10 of 19×1.06

CPROFcorporate profits±4.1%5 of 12×0.86

FOMCrate decision±3.8%10 of 24×0.79

CPIconsumer prices±2.8%1 of 10×0.60

PPIproducer prices±2.4%6 of 10×0.50

Bar = avg |move| to ±7% · tick = ±4.8% avg day · ×base = |move| ÷ ±4.8% · min 6 releases

Earnings history

EPS -0.34 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Aug 14 '26 · confirmed	-0.34	—
Q2 FY26	—	-0.95	—
Q1 FY26	—	-0.38	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod